Diagnosing and Managing Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017–2023

2025/02/27 by S. Oro, Saskia Ingen-Housz-Oro, Ilaria Matei +48 · 1 voice
Medicine · #Autoimmune Bullous Skin Diseases #Drug-Induced Adverse Reactions #Urticaria and Related Conditions

paper · doi:10.1016/j.jid.2024.06.1295

openalex publication_date 2025/02/27 · crossref created 2025/02/27 · crossref issued 2025/07/01 · crossref published 2025/07/01 · crossref published-print 2025/07/01 · openalex created_date 2025/10/10 · crossref deposited 2026/07/02 · crossref indexed 2026/07/02 · openalex updated_date 2026/07/22

Citations

• SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
• ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
• Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches
• Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
• Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Discussions

• A review by Saskia Ingen-Housz-Oro et al., "Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023" doi.org/10.1016/j.ji... #JIDJournal [bsky, 0 points, 0 comments]